SOLVAY PHARMACEUTICALS GMBH

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 36219
 
  
 
C07D HETEROCYCLIC COMPOUNDS 24138
 
  
 
C12Q MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS 4121
 
  
 
A01N PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF 392
 
  
 
C07H SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 396
 
  
 
C07C ACYCLIC OR CARBOCYCLIC COMPOUNDS 2136
 
  
 
A61P THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 148
 
  
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 1166

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2009/0263,479 FORMULATIONS FOR POORLY PERMEABLE ACTIVE PHARMACEUTICAL INGREDIENTSApr 21, 09Oct 22, 09[A61K]

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
8288367 Substituted estratriene derivatives as 17BETA HSD inhibitorsNov 29, 07Oct 16, 12[A61K, C07J]
7820690 Method of treating or inhibiting a non-digestive tract derived abdominal disorder associated with pain using a 5-HT, receptor antagonistMar 16, 05Oct 26, 10[A61K]
7816347 Pharmaceutical compositions comprising NEP-inhibitors, inhibitors of the endogenous endothelin producing system and HMG CoA reductase inhibitorsDec 14, 05Oct 19, 10[A61K, A61P]
7772225 N-sulfamoyl-piperidineamides for the treatment or inhibition of obesity and related conditionsDec 08, 06Aug 10, 10[A61K, A01N, C07D]
7767692 1-amidomethylcarbonyl-piperidine compounds, methods and intermediate products for the production thereof and pharmaceutical formulations containing said compoundsNov 10, 03Aug 03, 10[A61K, C07D]
7763607 Pharmaceutical compositions comprising CBx cannabinoid receptor modulators and potassium channel modulatorsApr 26, 07Jul 27, 10[A61K]
7714150 -chroman-6-yl derivativesApr 10, 06May 11, 10[C07D]
7592344 NK1 and NK2-antagonists and compositions and methods of using the sameNov 30, 06Sep 22, 09[A61K]
7547708 N-sulfamoyl-N′-benzopyranpiperidine compounds and uses thereofNov 14, 06Jun 16, 09[A61K, C07D]
7534903 -chromen-6-yl-compounds in the treatment of cardiac arrhythmia and other disease statesJan 18, 08May 19, 09[A01N, C07D]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2010/0323,012 Pharmaceutical Compositions Comprising NEP-Inhibitors, Inhibitors of the Endogenous Endothelin Producing System and DiureticsAbandonedAug 31, 10Dec 23, 10[A61K, A61P, B65D]
2010/0203,132 Pharmaceutical Compositions Comprising NEP-Inhibitors, Inhibitors of the Endogenous Endothelin Producing System and AT1 Receptor AntagonistsAbandonedApr 21, 10Aug 12, 10[A61K, A61P, B65D]
2009/0104,126 Sulfamate Compounds and Uses ThereofAbandonedOct 17, 08Apr 23, 09[A61K, C07C]
2008/0317,726 Proteases for Pharmaceutical UseAbandonedJun 16, 06Dec 25, 08[A61K, C12N, A61P]
2008/0249,075 C11 Modified Retrosteroids as Progesterone Receptor Modulator CompoundsAbandonedMar 20, 08Oct 09, 08[A61K, C12Q, A61P, C07J]
2008/0045,551 PHARMACEUTICAL COMBINATION COMPRISING AN ADENOSINE A1 ANTAGONIST AND A RADIOCONTRAST MEDIAAbandonedJun 19, 07Feb 21, 08[A61K, A61P]
2008/0027,082 USE OF ADENOSINE A1 ANTAGONISTS IN RADIOCONTRAST MEDIA INDUCED NEPHROPATHYAbandonedJun 19, 07Jan 31, 08[A61K, A61P]
2007/0254,863 Use of CBx cannabinoid receptor modulators as potassium channel modulatorsAbandonedApr 26, 07Nov 01, 07[A61K]
7273860 Method and pharmaceutical compositions for treating or inhibiting renal dysfunctions, diseases or disorders, particularly in diabetic patientsExpiredNov 16, 04Sep 25, 07[A61K]
2007/0219,214 Dual NK2/NK3-antagonists, pharmaceutical compositions comprising them, and processes for their preparationAbandonedFeb 01, 07Sep 20, 07[A61K, C07D]
2007/0212,751 Microbial method for the 11beta hydroxylation of 9beta, 10alpha-steriodsAbandonedJan 16, 07Sep 13, 07[C12P, C12N]
2007/0191,357 METHODS OF USING POTASSIUM CHANNEL INHIBITING COMPOUNDSAbandonedAug 17, 06Aug 16, 07[A61K]
2007/0082,876 Novel C18 modified retrosteroids as progesterone receptor modulator compoundsAbandonedSep 29, 06Apr 12, 07[A61K, C07J]
2007/0082,905 PHARMACEUTICAL COMPOSITIONS COMPRISING N-TRIAZOLYMETHYL-PIPERAZINE COMPOUNDS AND METHODS OF USING SAMEAbandonedMay 22, 06Apr 12, 07[A61K]
7189709 Method and pharmaceutical compositions for treating or inhibiting renal dysfunctions, diseases or disorders, particularly in diabetic patientsWithdrawnNov 16, 04Mar 13, 07[A61K]
2006/0281,997 Arrhythmogenic risk management tools and methods of useAbandonedJun 06, 06Dec 14, 06[A61B]
2006/0205,625 Pharmaceutical compositions comprising NEP-inhibitors, inhibitors of the endogenous endothelin producing system and diureticsAbandonedFeb 17, 06Sep 14, 06[C11D]
2006/0178,520 Process for preparing medrogestoneAbandonedJan 17, 06Aug 10, 06[C07J]
2005/0288,272 Pharmaceutical compositions comprising NEP-inhibitors, inhibitors of the endogenous endothelin producing system and AT1 receptor antagonistsAbandonedJun 20, 05Dec 29, 05[A61K]
2005/0267,072 Pharmaceutical compositions containing dually acting inhibitors of neutral endopeptidase for the treatment of sexual dysfunctionAbandonedMay 12, 05Dec 01, 05[A61K]

View all patents..

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.